Add to Calendar2019-09-20 08:00:002019-09-21 11:15:00Emerging Topic Conference: The Genomics Revolution
The conference will focus on genomics and the changing approach to diagnostics, management and research in adult and pediatric liver diseases.
Arlington, VA 22202
Add to Calendar2019-10-04 08:00:002019-10-05 14:00:00AASLD / EASL ALD Conference
This meeting will bridge critical gaps in ALD diagnosis, management and clinical trial design.
1 W. Wacker Drive
Chicago, IL 60601
Add to Calendar2019-11-08 09:00:002019-11-12 14:00:00The Liver Meeting
The Liver MeetingÂ® is the annual must-attend event bringing together 9,500 attendees from around the world to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field.
Add to Calendar2019-12-14 08:00:002019-12-15 17:00:00TASL-AASLD Joint Symposium: HBV Elimination
Doctors Anna S. Lok and K. Rajender Reddy will join Dr. Jia-Horng Kao and other faculty from Taiwan to host the first TASL-AASLD Joint Symposium as part of the TASL (Taiwan Association for the Study of the Liver) Annual Meeting, December 14-15, 2019 in Taipei.
Beitou District, Taipei City
Add to Calendar2020-03-20 08:00:002020-03-21 15:00:00Emerging Topic Conference: Nuclear Receptors as Common Clinical Targets for the Treatment of Cholestatic and Nonalcoholic Fatty Liver Diseases
More information is coming soon.
LiverLearningÂ® is the official eLearning portal of AASLD. Users can access educational resources by topic, speaker, event, and content type â€” including video, audio, and slide decks. Continuing education (CME/CE credits and MOC points) is available for a variety of enduring materials on the portal. All current AASLD members automatically receive complete access to LiverLearningÂ®, and non-members can purchase access for one year with a subscription.
The Aflac Cancer and Blood Disorders Center, Childrens Healthcare of Atlanta and Emory University Department of Pediatrics, invites applications for a faculty position within our Immune Dysregulation and Immunohematology Program. Qualified candidates should be Board Certified/Eligible Hematologist/Oncologists or Allergy/Immunology. Preference will be given to applicants with experience in the evaluation and management of immune dysregulation patients and Hematopoietic stem cell transplant. Clinical effort and research commitment are flexible depending on the candidates interests and training. About the Aflac Cancer and Blood Disorders Center In Aflacs Immune Dysregulation and Immune Hematology Program, one of our missions is to pr
This job listing is no longer active.
Check the left side of the screen for similar opportunities.